News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,127 Results
Type
Article (88227)
Company Profile (823)
Press Release (785056)
Multimedia
Podcasts (209)
Webinars (32)
Section
Business (233364)
Career Advice (4152)
Deals (39900)
Drug Delivery (160)
Drug Development (91491)
Employer Resources (205)
FDA (18450)
Job Trends (17442)
News (398172)
Policy (39999)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3025)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (166)
Alliances (56982)
ALS (196)
Alzheimer's disease (1837)
Antibody-drug conjugate (ADC) (385)
Approvals (18651)
Artificial intelligence (694)
Autoimmune disease (213)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (491)
Bladder cancer (178)
Brain cancer (70)
Breast cancer (704)
Cancer (5413)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (882)
Cervical cancer (41)
Clinical research (77540)
Collaboration (1988)
Company closure (6)
Compensation (1262)
Complete response letters (86)
COVID-19 (3007)
CRISPR (110)
C-suite (989)
Cystic fibrosis (157)
Data (6815)
Decentralized trials (2)
Denatured (77)
Depression (170)
Diabetes (561)
Diagnostics (7344)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (339)
Drug pricing (232)
Drug shortages (36)
Duchenne muscular dystrophy (271)
Earnings (100879)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (136022)
Executive appointments (1081)
FDA (21862)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1668)
Gene editing (235)
Generative AI (72)
Gene therapy (729)
GLP-1 (1178)
Government (5488)
Grass and pollen (8)
Guidances (390)
Healthcare (20990)
HIV (77)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (312)
Immuno-oncology (81)
Indications (140)
Infectious disease (3332)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (270)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (23)
Lung cancer (721)
Lymphoma (401)
Machine learning (49)
Management (66)
Manufacturing (949)
MASH (187)
Medical device (15106)
Medtech (15176)
Mergers & acquisitions (23062)
Metabolic disorders (1510)
mRNA (208)
Multiple sclerosis (181)
NASH (23)
Neurodegenerative disease (395)
Neuropsychiatric disorders (110)
Neuroscience (3287)
Neurotech (1)
NextGen: Class of 2026 (7711)
Non-profit (5127)
Now hiring (70)
Obesity (739)
Opinion (350)
Ovarian cancer (178)
Pain (238)
Pancreatic cancer (256)
Parkinson's disease (328)
Partnered (39)
Patents (555)
Patient recruitment (568)
Peanut (65)
People (67220)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23954)
Phase 2 (33650)
Phase 3 (25350)
Pipeline (6383)
Policy (364)
Postmarket research (3554)
Preclinical (10741)
Press Release (72)
Prostate cancer (275)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1040)
Real estate (7445)
Recruiting (81)
Regulatory (29426)
Reports (69)
Research institute (2749)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (91)
Schizophrenia (166)
Series A (281)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (180)
Sponsored (49)
Startups (4342)
State (2)
Stomach cancer (21)
Supply chain (123)
Tariffs (101)
The Weekly (129)
Vaccines (1198)
Venture capital (104)
Weight loss (505)
Women's health (108)
Worklife (23)
Date
Today (147)
Last 7 days (710)
Last 30 days (3304)
Last 365 days (32837)
2026 (6443)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (357)
Arkansas (15)
Asia (51728)
Australia (9091)
California (12347)
Canada (3513)
China (1250)
Colorado (522)
Connecticut (542)
Delaware (368)
Europe (119075)
Florida (1837)
Georgia (399)
Hawaii (4)
Idaho (68)
Illinois (1034)
India (82)
Indiana (580)
Iowa (24)
Japan (474)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1531)
Massachusetts (9081)
Michigan (381)
Minnesota (698)
Mississippi (7)
Missouri (149)
Montana (37)
Nebraska (30)
Nevada (137)
New Hampshire (88)
New Jersey (3321)
New Mexico (33)
New York (3258)
North Carolina (1701)
North Dakota (10)
Northern California (5976)
Ohio (380)
Oklahoma (23)
Oregon (55)
Pennsylvania (2462)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (72)
South Dakota (1)
Southern California (4795)
Tennessee (196)
Texas (1948)
United States (44457)
Utah (372)
Vermont (1)
Virginia (312)
Washington D.C. (88)
Washington State (1022)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 874,127 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
March 11, 2026
·
5 min read
Press Releases
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
March 11, 2026
·
6 min read
Press Releases
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
March 11, 2026
·
10 min read
Press Releases
Advancing Diagnostic Care: Saskatchewan’s First Modular MRI Cassette™ to House One of Canada’s First MAGNETOM Flow.Elite MRI Systems
March 11, 2026
·
5 min read
Press Releases
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
March 11, 2026
·
7 min read
Press Releases
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting
March 11, 2026
·
7 min read
Press Releases
Alkermes to Present at the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Mergers & acquisitions
Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles
Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality and a declining stock of available biotechs with mature assets.
March 11, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
1 of 87,413
Next
